SLI
1.978,73
PKT
-31,89
PKT
-1,59
%
Werbung
Analysen zu SLI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
06.11.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
05.11.15 | Zurich Insurance Sell | S&P Capital IQ | |
05.11.15 | Novartis overweight | JP Morgan Chase & Co. | |
05.11.15 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
04.11.15 | Swiss Re kaufen | Norddeutsche Landesbank (Nord/LB) | |
04.11.15 | Roche buy | Deutsche Bank AG | |
04.11.15 | UBS Hold | Deutsche Bank AG | |
04.11.15 | UBS Neutral | Nomura | |
04.11.15 | UBS Neutral | JP Morgan Chase & Co. | |
04.11.15 | Swiss Re Underperform | Credit Suisse Group | |
04.11.15 | Holcim Neutral | UBS AG | |
04.11.15 | UBS buy | Société Générale Group S.A. (SG) | |
04.11.15 | Nestlé overweight | Morgan Stanley | |
03.11.15 | UBS buy | Citigroup Corp. | |
02.11.15 | Swiss Re Neutral | UBS AG | |
30.10.15 | Swiss Re Underperform | BNP PARIBAS | |
30.10.15 | Swiss Re Neutral | JP Morgan Chase & Co. | |
30.10.15 | Swiss Re buy | Citigroup Corp. | |
30.10.15 | UBS Neutral | UBS AG | |
29.10.15 | Swiss Re buy | S&P Capital IQ | |
29.10.15 | Swiss Re kaufen | DZ-Bank AG | |
29.10.15 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
29.10.15 | Richemont overweight | JP Morgan Chase & Co. | |
28.10.15 | Novartis Halten | Independent Research GmbH | |
28.10.15 | Novartis Outperform | Bernstein Research | |
28.10.15 | Novartis buy | Kepler Cheuvreux | |
28.10.15 | Novartis overweight | JP Morgan Chase & Co. | |
28.10.15 | Novartis Hold | Deutsche Bank AG | |
28.10.15 | UBS Neutral | JP Morgan Chase & Co. | |
28.10.15 | Novartis Equal weight | Barclays Capital | |
28.10.15 | Richemont Outperform | BNP PARIBAS | |
28.10.15 | Richemont buy | Goldman Sachs Group Inc. | |
28.10.15 | Roche buy | UBS AG | |
28.10.15 | Novartis Hold | Société Générale Group S.A. (SG) | |
27.10.15 | Novartis Hold | S&P Capital IQ | |
26.10.15 | Novartis overweight | JP Morgan Chase & Co. | |
26.10.15 | Richemont overweight | JP Morgan Chase & Co. | |
26.10.15 | Givaudan overweight | JP Morgan Chase & Co. | |
23.10.15 | Roche overweight | JP Morgan Chase & Co. | |
23.10.15 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. |